Screening for Anal Cancer Precursors in Women
Screening Women With Prior HPV for Anal Neoplasia
Recruiting
N/A
Interventional Study
HPV-related Lower Genital Tract Neoplasias
HPV-related Anal Neoplasias
Early Stage Lower Genital Tract Cancers
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 35 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 300 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Other
Who this trial is looking for
This trial is looking for women who have a history of certain HPV-related diseases and cancers. Participants will be screened for early signs of anal cancer.
Are You a Good Fit for This Trial?
You may be able to join if
- I have a history of high-grade HPV-related disease or cancer.
- I am at least 35 years old.
- I have documented proof that I am HIV negative.
- I speak either English or Spanish.
- I have been treated at Mount Sinai Health System or Harris Health System.
You may not be able to join if
- I have had a high-resolution anoscopy before.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this single arm trial is to prospectively evaluate screening methods for anal cancer precursors in HIV uninfected women with a history of lower genital tract neoplasias and cancers.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women with a history of pathologically proven high-grade genital HPV-associated neoplastic disease (cervical intraepithelial neoplasia 2+, vulvar intraepithelial neoplasia 2+, or vaginal intraepithelial neoplasia 2+, or history of non-metastatic cervical, vaginal or vulvar can…
Contacts